Sponsored Links

Immunovaccine Presents Results For An Enhanced Anthrax Vaccine Candidate PDF Print E-mail
Medical News - Bio-terrorism
Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has been invited to present at the Canada - U.S. Partners in Biomedical Defense II Conference in Washington, D.C. on Wednesday, February 10, 2010...

Read more: Bio-terrorism / Terrorism News From Medical News Today